REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/11/2026
Back to search
Official data from USPTO
AGOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AGOS
ST13
US500000088718586Class
9, 35, 38, 42, 44
Filing
88718586
Registration
6344572
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/12/2026
Trademark type
Word
Nice classes
9, 35, 38, 42, 44
Filing date
12/06/2019
Registration date
05/11/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/11/2021
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Hitchin, GB
Examiner
REID, CAILE MAUREEN
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Agos Healthcare Limited
Representatives
Richard M. LaBarge MARSHALL, GERSTEIN & BORUN LLP
Technical classification
Nice Classes
Class 9Class 35Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable and recorded computer software for use as a database and for analysing data in the fields of pharmaceuticalsclinical trialsclinical research and biotechnology; Downloadable software applications for computerslaptops and mobile phones featuring software for use as a database and for collatingstoringanalysingutilizing data in the fields of pharmaceuticalsclinical trialsclinical research and biotechnology; Downloadable and recorded software for secure data storage and retrieval and transmission of customer and client information; Downloadable and recorded computer software for use as a database and for collatingstoringanalysing and utilizing data in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; downloadable and recorded computer operating programs and downloadable and recorded application development software for use on or in connection with mobile phonestablets and handheld devices in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; data processing equipment and computers; Downloadable electronic publications in the nature of e-booksmagazinesnewsletters and reports provided on-line from a database or the internet in the fields of pharmaceuticalsclinical trialsclinical research and biotechnology
Class 35
Business project and risk management services in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; business consultancy services; Business project and risk management and consultancy services in the field of clinical trials and clinical research; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management services for medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; providing business information management services on clinical trials and clinical research; providing business intelligence services in the fields of medical devicespharmaceuticals and the life sciences; providing business management information in connection with consultancy and advisory services in the field of strategic planning; regulatory submission managementbusiness strategic planningpreparing and submitting applications for others for new medical devicesnew pharmaceuticalsvariations on previously approved medical devicesvariations on previously approved pharmaceuticals to receive clinical trial approval or marketing authorization from governmental regulatory bodies; regulatory submission managementassisting others with strategic business planningpreparing and filing applications with governmental regulatory bodies for approval of new medical devices and new pharmaceuticals; Regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; New pharmaceutical and biotechnology product commercialization services; consultancy services for others in the field of new pharmaceutical and biotechnology product commercialization; informationadvice and consultancy services in relation to all the aforesaid services
Class 38
Providing Internet accessproviding access to platforms and portals on the internet in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; providing user access to global computer networksproviding user access to platforms and portals on the internet in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; informationadvice and consultancy services in relation to all the aforesaid services
Class 42
Providing medical and scientific research information in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; Product and scientific research and development in the field of pharmaceuticalsclinical trialsclinical researchmedical devices and biotechnology; Consultancy services for others in the field of technical consultancy for pharmaceuticalsdesignplanningimplementation consultancy for clinical trialsconsultancy on scientific clinical researchdesign and development consultancy for medical devices; conducting early evaluations in the field of new pharmaceuticals; consultancy services in the field of designplanningimplementation and project management of clinical trialspharmacovigilancepharmaceutical and biotechnology product development; consultancy services in the fields of biotechnologypharmaceutical research and developmentlaboratory testing and pharmacogenetics; medical and scientific research; conducting clinical trials for others; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development; product development consultancy in the field of pharmaceuticals and biotechnology; testing and quality control evaluation of products in the field of pharmaceuticalsclinical trials and biotechnology; product testing and quality control evaluation of pharmaceutical preparations and medicines; testing and quality control in the nature of conducting clinical trials in the field of pharmaceuticals and biotechnology for others; Software as a Service (SaaS) featuring software for use as a database and for analysing data in the fields of in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; providing online non-downloadable software applications for use in creatingdesigninghostingpublishingmanaging and maintaining content for use on the internet for website and media content management purposes; application service provider featuring application programming interface (API) software to allow people to view data through an interactive mapto query datato generate reports and to access data and documents; software as a service (SAAS) featuring computer software to enable the displayingreceiving and transmitting of data to enable the purchase of goods and services; informationadvice and consultancy services in relation to all the aforesaid services
Class 44
Managed healthcare services being medical services in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; consultancy services in the field of medical information services; medical consultancy services in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; consultancy services in the field of biotechnology diagnostics and pharmacogenetics diagnostics medical testing; medical informationadvice and consultancy services in the pharmaceutical and healthcare sectors; medical informationadvice and consultancy services in relation to pharmacovigilance; informationadvice and consultancy services in relation to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/23/2021
PUBO
PUBLISHED FOR OPPOSITION
02/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
01/21/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/21/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
01/21/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/19/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/19/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/26/2020
GNFR
FINAL REFUSAL E-MAILED
10/26/2020
CNFR
FINAL REFUSAL WRITTEN
10/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2020
ALIE
ASSIGNED TO LIE
10/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2020
GNRT
NON-FINAL ACTION E-MAILED
03/09/2020
CNRT
NON-FINAL ACTION WRITTEN
03/09/2020
DOCK
ASSIGNED TO EXAMINER
03/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2019
NWAP
NEW APPLICATION ENTERED
12/10/2019
Continuous trademark protection
Get notified about every new filing that threatens AGOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.